Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. W. S. Ko, Y. Y. Lam, B. P. Y. Yan, J. H. Y. Chu, D. S. C. Hui (Hong Kong, Hong Kong). High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease. Eur Respir J 2014; 44: Suppl. 58, 2939

Member's Comments

No comment yet.

Related content which might interest you: Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD) Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Diabetes mellitus and obstructive pulmonary disease. Is there an association? Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Characteristics of patients with persistent airflow obstruction from an asthma clinic Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Tree years survival rates of COPD patients that hospitalized for acute excecerbation of COPD Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015